Side effects

Constipation on GLP-1: fiber and fluid strategies

Constipation is a common side effect of GLP-1 receptor agonist therapy. Practical nutritional strategies — graduated fiber increase, adequate fluid, considered movement — and when to involve the clinician.

Constipation is a common side effect of GLP-1 receptor agonist therapy. The slowing of gastrointestinal motility that produces the satiety effect also slows colonic transit, and reduced caloric intake (and reduced fluid intake along with it) compounds the effect. Most cases are responsive to nutritional adjustment; some require clinician input for additional measures.

Why constipation is common on GLP-1

Three mechanisms contribute:

1. Slowed GI motility is part of the medication’s pharmacology. The same mechanism that produces the satiety effect contributes to slower colonic transit.
2. Reduced food intake reduces the bolus volume and the fiber load that drives normal colonic transit.
3. Reduced fluid intake — common as thirst sensation diminishes with appetite — compounds both of the above.

Graduated fiber strategies

Increasing dietary fiber is the most-cited nutritional intervention, but the manner of the increase matters. A sudden large increase in fiber can worsen GI symptoms (gas, bloating, occasional cramping) and is sometimes counterproductive. The practical pattern:

• Start small and increase gradually. Add 5 g of additional fiber per day, hold for 4-7 days, then add another 5 g if tolerance is good. Continue toward a target of approximately 25-30 g total daily fiber for most adults (clinical target may differ).
• Include both soluble and insoluble fiber. Oats, beans, lentils, fruits with skin, and vegetables provide the mix.
• Distribute across meals. Loading fiber into a single meal is harder than spreading it across the day.

Common food sources that work well in this graduated pattern: oatmeal, berries, beans, lentils, ground flax (1-2 tablespoons per day), chia seeds, leafy greens, fruit with skin.

For some patients, a fiber supplement (psyllium husk, methylcellulose) is the most reliable way to consistently meet the target. Discuss with your clinician or pharmacist; some fiber supplements have interactions with other medications or specific timing requirements.

Fluid adequacy

Fluid intake should generally rise alongside fiber intake. Fiber without adequate fluid is sometimes worse for constipation than no additional fiber. A practical fluid pattern:

• A glass of water on waking.
• Glasses of water between meals (not during, which can compound early satiety).
• A glass of water in the evening.
• More on hot days or with exercise.

Patients with reduced thirst sensation on GLP-1 often benefit from a structured fluid schedule rather than relying on thirst.

Movement

Regular movement (walking, light to moderate physical activity) supports normal colonic transit. The clinical recommendation is approximately 150 minutes per week of moderate-intensity aerobic activity for most adults; this is the same recommendation for cardiometabolic health more broadly and applies on GLP-1 as elsewhere.

For constipation specifically, even a 10-15-minute walk after meals tends to support transit.

When the strategies are not enough

Constipation that does not respond to graduated fiber, fluid, and movement adjustment is a reason to involve the clinician. Several options exist that are clinical decisions rather than nutritional ones:

• Osmotic agents (polyethylene glycol, magnesium-based options) used short-term.
• Stimulant laxatives used short-term and not as a long-term strategy.
• Probiotic options (variable evidence).
• Reassessment of the medication dose or titration pace.

These are conversations with the prescribing clinician. Specific symptoms that warrant prompt clinician contact rather than continued self-management:

• No bowel movement for >5-7 days despite the strategies above.
• Severe abdominal pain, particularly with abdominal distension.
• Vomiting.
• Blood in stool.
• Symptoms suggestive of bowel obstruction.

Coffee, prunes, and the older remedies

Coffee in the morning is a legitimate and often-effective stimulus to bowel motility for some patients. Prunes (and prune juice) provide a combination of fiber and sorbitol that supports transit. Both are reasonable additions to the graduated-fiber and fluid pattern; neither is required.

Common questions

“Does the constipation get better over time?” For many patients, yes — colonic transit accommodates and constipation diminishes after the first weeks. For others, it persists at the maintenance dose and requires ongoing fiber/fluid/movement attention.

“Is the constipation a sign the medication is ‘working too well’?” The slowed motility is part of the pharmacology, not necessarily an “overdose” sign. Persistent constipation with severe symptoms is a reason to discuss dose with your clinician.

“What about magnesium?” Magnesium-containing supplements (citrate, oxide forms) are sometimes used at low dose to support transit. They have a separate role in micronutrient sufficiency on GLP-1 (magnesium is one of the at-risk micronutrients). Discuss dose and form with your clinician or pharmacist.

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.
3. McRorie JW, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. Journal of the Academy of Nutrition and Dietetics. 2017;117(2):251-264.
4. Bharucha AE, Pemberton JH, Locke GR. American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218-238.
5. American Diabetes Association. Standards of Care in Diabetes — 2025: Section 5, Facilitating positive health behaviors and well-being. Diabetes Care. 2025;48(Suppl 1):S77-S110.